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Abstract 
Background: The traditional methods used in the diagnosis of dengue infection do not lend themselves to field 
application. As such, clinical specimens have to be sent to a central aboratory for processing which invariably leads 
to delay. This affects patient management and disease control. The development of the dengue IgM dot enzyme 
immunoassay has opened up the possibility of carrying out the test in peripheral health settings. 
Ob~tives: This multicentre study was conducted to evaluate a new, commercial nitrocellulose membrane based 
IgM capture nzyme immunoassay. 
Study design: The sensitivity and specificity of the test were compared with in-house dengue IgM enzyme-linked 
immunoassays routinely performed by each of the selected centres. Known positive and negative dengue specimens, 
as well as specimens from non-dengue cases, were included in the evaluation. 
Results: Based on 402 specimens tested by the six centres, the sensitivity was 92.1% and specificity 88.1%, with an 
overall agreement of 92.8% when compared with IgM EIA assays performed on microplates. 
CoaelusiaB_s: The results suggest that this commercial kit has a role to play in the diagnosis of dengue infection, 
especially in peripheral health settings. © 1996 Elsevier Science B.V. All rights reserved 
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1. Introduction 
Methods which are currently available for the 
laboratory diagnosis of dengue infections do not 
lend themselves easily to field application. As such, 
clinical specimens have to be despatched tocentral 
laboratories for processing. This will invariably 
create problems and lead to delay in diagnosis, 
which in turn will affect patient management and 
disease control. Cardosa et al. (1988b) reported the 
development of a dot enzyme immunoassay for the 
detection of dengue antibodies. This formed the 
basis of a commercial dengue blot kit in which the 
viral antigens are bound to nitrocellulose mem- 
branes instead of microplates, and the antibodies 
are visualized using Protein A which is labelled with 
the enzyme horseradish peroxidase. This kit has 
been evaluated by various workers and was found 
to be particularly useful in detecting secondary 
dengue infections (Cardosa et al., 1988a; Fang et 
al., 1992) and less so for primary dengue infections. 
Using the same principle, Cardosa et al. (1995) 
developed a nitrocellulose membrane based IgM 
capture enzyme immunoassay (MAC DOT) for 
diagnosis of dengue virus infections. The MAC 
DOT was tested on several sample sets including a
retrospective study of 119 patients from Thailand 
with confirmed engue infection. The sensitivity of 
the test was shown to be 94% taking only admission 
sera into consideration but rose to 99% when both 
an admission and a discharge specimen were con- 
sidered. Other sample sets confirmed the high 
sensitivity and a study of 494 unselected febrile 
children showed that the specificity of the MAC 
DOT was 98%. 
A multicentre evaluation of the MAC DOT was 
undertaken at the request of the World Health 
Organization, Geneva, and coordinated by the 
WHO Collaborating Centre for DF/DHF, Kuala 
Lumpur, Malaysia. 
This is the report of the evaluation study pre- 
pared by the WHO Collaborating Centre. 
2. Materials and methods 
2.1. Participating centres 
Laboratories located in the following six centres 
participated in the evaluation: Malaysia (Centre 
1), Singapore (Centre 2), Tahiti (Centre 3), Japan 
(Centre 4), Puerto Rico (Centre 5) and Thailand 
(Centre 6). 
3. MAC DOT kits 
The MAC DOT kits were provided free by the 
manufacturer, Venture Technologies (Malaysia), 
through the courtesy of Prof. M.J. Cardosa, Uni- 
versity Malaysia Sarawak, Malaysia. The MAC 
DOT is similar to the IgM capture ELISA or 
MAC ELISA (Lam et al., 1987; Innis et al., 1989) 
with the important difference being the use of 
nitrocellulose membranes instead of 96 well mi- 
crotitre plates. The dengue antigens used in the 
MAC DOT consist of all four dengue serotypes 
prepared from C6/36 infected cells and a dengue 
group reactive monoclonal ntibody was used for 
the detection of bound antigens. The full details 
of the test are contained in the paper by Cardosa 
et al. (1995). 
3. I. In-house dengue IgM ELISA 
The in-house dengue IgM ELISA used by Cen- 
tre 1 has been published (Lam et al., 1987). 
Briefly, 96-well microplates coated with rabbit 
anti-human IgM were reacted with test sera. The 
antigen used was dengue 2, prepared in suckling 
mouse brains and the monoclonal antibody 
(WRAIR-2 3H5) to dengue 2 was used for detec- 
tion of bound antigen. 
In Centre 2, the method of Cardosa et al. 
(1995) was used. The main difference between 
this IgM ELISA format and that used in Centre 1 
was the use of a cocktail of all four types of 
dengue antigens prepared in C6/36 cells. The 
bound antigen was detected by a group reactive 
monoclonal 4G2 antibody obtained from the 
American Type Culture Collection hybridoma 
line. 
In Centre 3, an in-house dengue IgM antibody 
capture ELISA was used (Chungue t al., 1989). 
Dengue 1 and dengue 3 antigens prepared in 
suckling mice were used and the detecting anti- 
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body was homologous mouse hyperimmune 
ascitic fluid. • 
Centre 4 used the method described by Bundo 
and Igarashi (1985). Dengue 2-infected C6/36 
cell culture fluid was used as antigen and the 
detecting antibody was a conjugated anti- 
flavivirus human lgG. 
Both Centres 5 and 6 used the method of 
Innis et al. (1989). Tetravalent dengue antigen 
diluted in phosphate buffered saline plus 20% 
acetone xtracted normal human serum was used 
followed by an overnight incubation step. The 
detecting antibody was horseradish peroxidase 
conjugated human anti-flavivirus IgG also di- 
luted in 20% acetone extracted normal human 
serum. 
3.2. Specimens 
3.2.1. Centre I 
The serum specimens used in the Malaysian 
study consisted of 87 samples from 70 patients. 
Of these 87 samples, 52 were dengue IgM posi- 
tive and 35 IgM negative. Among the dengue 
IgM negative samples, 2 each were from con- 
firmed rubella, measles and typhoid fever cases. 
study consisted of 40 samples. Of these, 20 were 
low to medium dengue IgM ELISA positive and 
20 were dengue IgM negative. This was the only 
centre where the specimens were not tested 
blind. 
3.2.6. Centre 6 
The serum specimens used in the Thailand 
study consisted of 72 samples from 41 patients. 
Of these, 46 were IgM positive and 26 IgM neg- 
ative. Among the negative samples, there were 7 
from confirmed Japanese ncephalitis and 4 were 
malaria positive samples. 
3.3. Sensitivity and specificity 
The sensitivity and specificity of the MAC 
DOT over IgM ELISA were calculated by divid- 
ing the number of MAC DOT positive or nega- 
tive samples by the total positive or negative 
samples, respectively. The overall agreement was 
the sum of the positive and negative samples by 
both methods divided by the total number of 
samples tested. 
4. Results 
3.2.2. Centre 2 
The serum specimens used in the Singapore 
study consisted of 72 specimens. Of these, 39 
were dengue IgM positive by ELISA and 33 
were IgM negative. 
3.2.3. Centre 3 
The serum samples used in the Tahiti study 
consisted of 68 samples. Of the 68 samples, 49 
were dengue IgM ELISA positive including 12 
which were weakly positive and 19 were IgM 
negative. 
3.2.4. Centre 4 
The serum samples used in the Japan study 
consisted of 63 samples from Myanmar. Of 
these, 58 were IgM positive and 5 were IgM 
negative. 
3.2.5. Centre 5 
The serum specimens used in the San Juan 
Table 1 presents a summary of the results 
from each of the six centres and Table 2 sum- 
marizes the sensitivity, specificity and overall 
agreement of the MAC DOT compared with the 
IgM ELISA. 
Of the 87 samples tested in Centre 1 
(Malaysia), 51 were both MAC DOT and IgM 
ELISA positive and 30 were MAC DOT and 
IgM ELISA negative, including two samples 
each from confirmed rubella, measles and ty- 
phoid fever. One sample was IgM ELISA posi- 
tive and MAC DOT negative, while 5 were 
MAC DOT positive and IgM ELISA negative. 
Of these 5 samples, 4 were false negative by 
IgM ELISA since they were found subsequently 
to be presumptive positive by haemagglutination 
inhibition with HI titres greater than 1:1280. 
The overall agreement was 93.1% with a sensi- 
tivity of 98.1% and specificity of 85.7% (Table 
2). If we take into consideration the 4 false neg- 
ative samples, the specificity would be higher. 
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Table 1 
Comparison of MAC DOT with IgM ELISA 
Centre MAC DOT ELISA 
Positive Negative Total 
1 Positive 51 5 56 
Negative 1 30 31 
Total 52 35 87 
2 Positive 37 0 37 
Negative 2 33 35 
Total 39 33 72 
3 Positive 42 l 43 
Negative 7 18 25 
Total 49 19 68 
4 Positive 57 2 59 
Negative 1 3 4 
Total 58 5 63 
5 Positive 16 0 16 
Negative 4 20 24 
Total 20 20 40 
6 Positive 44 3 47 
Negative 2 23 25 
Total 46 26 72 
Of the 72 samples tested in Centre 2 (Singa- 
pore), 37 were both MAC DOT and IgM ELISA 
positive and 33 were MAC DOT and IgM ELISA 
negative. There were 2 samples which were IgM 
ELISA positive but MAC DOT negative. The 
overall agreement was 97.2% with a sensitivity of 
94.9% and specificity of 100%. 
Of the 68 samples tested in Centre 3 (Tahiti), 42 
were both MAC DOT and IgM ELISA positive 
and 18 were both MAC DOT and IgM ELISA 
negative. Seven samples were IgM ELISA positive 
and MAC DOT negative and one was MAC 
DOT positive but IgM negative. The overall 
agreement was 88.2% with a sensitivity of 85.7% 
and specificity of 94.7%. Discrepant results oc- 
curred mostly with specimens which were weakly 
positive by either IgM ELISA or by MAC DOT. 
Of the 63 samples tested in Centre 4 (Japan), 57 
were both MAC DOT and IgM ELISA positive 
and 3 were MAC DOT and lgM ELISA negative. 
There was 1 sample which was IgM ELISA posi- 
tive and MAC DOT negative and 2 which were 
MAC DOT positive but IgM negative. The over- 
all agreement was 95.2% with a sensitivity of 
98.3% and specificity of 60%. The low value for 
specificity was due to the small sample size of 
negative specimens. 
Of the 40 samples tested in Centre 5 (Puerto 
Rico), 16 were both MAC DOT and IgM ELISA 
positive and 20 were MAC DOT and IgM ELISA 
negative, 4 samples were IgM ELISA positive but 
MAC DOT negative. The overall agreement was 
90% with a sensitivity of 80% and specificity of 
100%. The sensitivity could have been higher if 
the sample size included strongly positive speci- 
mens. 
Of the 72 samples tested in Centre 6 (Thailand), 
44 were both MAC DOT and IgM ELISA posi- 
tive and 23 were MAC DOT and IgM ELISA 
negative. Among the 23 negative samples, there 
were 7 confirmed Japanese ncephalitis cases and 
4 malaria positive cases. Of the 2 samples which 
were IgM ELISA positive but MAC DOT nega- 
tive, one was a definite false negative since the 
sample was also positive by HI and the other was 
a false dengue IgM ELISA positive due to cross- 
reaction with JE IgM ELISA in a confirmed JE 
Table 2 
Summary of results from the six centres 
Centre No. tested % Sensitivity % Specificity % Agreement 
1 87 98.1 85.7 93.1 
2 72 94.9 100.0 97.2 
3 68 85.7 94.7 88.2 
4 63 98.3 60.0 95.2 
5 40 80.0 100.0 90.0 
6 72 95.7 88.5 93.1 
Total 402 92. l 88.1 92.8 
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infection. Of the 3 samples which were IgM 
ELISA negative and MAC DOT positive, follow- 
up specimens from the three patients were subse- 
quently IgM ELISA positive, indicating that 
MAC DOT was able to detect dengue IgM earlier 
than IgM ELISA. The overall agreement was 
93.1% with a sensitivity of 95.7% and specificity 
of 88.5%. If we take into consideration the three 
patients whose early samples were IgM ELISA 
negative and became positive on follow-up sam- 
ples, the overall agreement would then be 97.2% 
with a sensitivity of 95.9% and a specificity of 
100%. 
Table 2 summarizes the results from the six 
centres based on a total of 402 samples. The 
sensitivity of MAC DOT as compared with the 
IgM ELISA ranges from 80 to 98.3% with an 
average of 92.1%. The specificity ranges from 60 
to 100% with an average of 88.1%. Two centres 
had I00% specificity and Centre 4 (Japan) had a 
specificity of 60% based on only 5 negative sam- 
ples. The overall agreement ranges from 88.2 to 
97.2% with an average of 92.8%. The only centre 
which was below 90% was Centre 3 (Tahiti). 
5. Discussion 
All six centres did not encounter any difficulty 
with the technical performance of the MAC DOT. 
There were some problems with the interpretation 
of the colour change since the reading was subjec- 
tive and the colour was quite faint, especially with 
weak IgM ELISA positive samples. The MAC 
DOT was more labour intensive when handling 
many specimens as compared to the conventional 
IgM ELISA. It also took slightly longer to carry 
out than some of the IgM ELISA formats used in 
this study as it required an overnight incubation 
step. Shorter incubation could result in loss of 
sensitivity and specificity (M.J. Cardosa, pers. 
comm.). 
Although the six centres used slightly different 
dengue IgM ELISA format, with different 
reagents, incubation times and cut-off criteria, the 
results obtained were in fairly close agreement. 
Four of the centres achieved sensitivity equivalent 
to that reported by Cardosa et al. (1995). Centre 
5 (San Juan) reported a lower sensitivity since the 
samples tested consisted of only low to medium 
dengue IgM ELISA positive samples. Four cen- 
tres reported specificity of over 80%. Centre 4 
(Japan) reported specificity of only 60% but this 
was based on very few negative samples. There 
was no false positive with non-dengue cases such 
as Japanese ncephalitis, rubella, measles and ty- 
phoid fever. Four malaria positive samples tested 
in Centre 6 (Thailand) were MAC DOT negative 
but of 30 malaria positive blood samples tested in 
Centre 1 (Malaysia) by MAC DOT, 7 (23.3%) 
were found to be weakly reactive (data not in- 
cluded) and negative by IgM ELISA. The reason 
for this cross-reactivity is not apparent. 
The MAC DOT appeared to be more sensitive 
than dengue IgM ELISA since three confirmed 
dengue cases tested in Centre 6 (Thailand) were 
IgM ELISA negative in the acute samples but 
were positive by MAC DOT. In Centre 1 
(Malaysia), 4 out of 5 high-titred HI dengue 
samples were positive by MAC DOT but negative 
by IgM ELISA. Since there are a number of such 
single samples ubmitted for dengue diagnosis, the 
MAC DOT has an advantage over the IgM 
ELISA used in Centre 1. 
With the development of this commercial kit, it 
should now be possible to decentralize the diag- 
nostic service to peripheral health settings where 
laboratories processed relatively few specimens. 
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